Azitra, Inc. (NYSEAMERICAN:AZTR) Shares Shorted: Short Interest Up 172.3% in October

Azitra, Inc. (NYSEAMERICAN:AZTR) saw a large increase in short interest in the month of October. As of October 30th, there was short interest totaling 305,802 shares, an increase of 172.3% from the October 15th total of 112,293 shares. Based on an average daily volume of 14,623,589 shares, the days-to-cover ratio is currently 0.0 days. Approximately 5.1% of the company’s stock are sold short.

Azitra Stock Up 14.2%

AZTR stock opened at $0.67 on Friday. The business’s 50-day moving average is $1.72 and its two-hundred day moving average is $1.86. Azitra has a 1 year low of $0.52 and a 1 year high of $4.30.

Azitra (NYSEAMERICAN:AZTR) last announced its quarterly earnings data on Thursday, November 12th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.04). On average, equities research analysts predict that Azitra will post -2.05 EPS for the current fiscal year.

About Azitra

Azitra, Inc. is a clinical-stage biotechnology company focused on developing microbiome-based therapies for dermatological conditions. The company combines microbiology, genetic engineering and computational tools to identify and develop targeted treatments intended to address diseases affecting the skin. Azitra’s platform centers on engineered strains of beneficial skin bacteria and biologic compounds designed to deliver therapeutic proteins or otherwise influence the skin’s local environment. Its development programs have focused on conditions including inflammatory skin disorders, rare genetic diseases and treatment-related dermatologic complications.